润达医疗(603108)6月30日股东户数6.55万户，较上期减少13.82%

Group 1 - The core point of the article highlights that RunDa Medical has seen a significant decrease in the number of shareholders, with a reduction of 10,501 accounts, representing a decline of 13.82% from March 31 to June 30, 2025 [1][2] - As of June 30, 2025, the average number of shares held per shareholder increased from 7,945 shares to 9,219 shares, while the average market value of shares held per account was 162,800 yuan [1][2] - Compared to the pharmaceutical commercial industry average, RunDa Medical's shareholder count of 65,478 is above the industry average of 40,100, but its average market value per account is below the industry average of 214,000 yuan [1][2] Group 2 - From March 31 to June 30, 2025, RunDa Medical's stock price experienced a decline of 10.85%, coinciding with the reduction in shareholder accounts [1][2] - During the same period, the net outflow of main funds was 283 million yuan, while retail investors saw a net inflow of 366 million yuan [2]